Daniel N. Swisher, Jr
Overview
Daniel N. Swisher, Jr received an average of $5M in total compensation, including $675K in salary, at Jazz Pharmaceuticals from 2018 to 2021. Daniel Swisher also received an average of $1M at Sunesis Pharmaceuticals from 2006 to 2017.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2012
- 2011
Jazz PharmaceuticalsPresident
Jazz PharmaceuticalsPresident and COO
Jazz PharmaceuticalsPresident and COO
Jazz PharmaceuticalsPresident and COO
Sunesis PharmaceuticalsFormer CEO and President
Sunesis PharmaceuticalsCEO and President
Sunesis PharmaceuticalsCEO and President
Sunesis PharmaceuticalsCEO and President
Sunesis PharmaceuticalsCEO and President
Sunesis PharmaceuticalsCEO and President
Source: SEC filings on June 10, 2022, June 11, 2021, June 12, 2020, June 14, 2019, April 25, 2018, April 20, 2017, April 25, 2013, April 21, 2011, April 28, 2010, and April 27, 2007.
Related executives
We found 35 more executives who work or worked at Jazz Pharmaceuticals and Sunesis Pharmaceuticals.
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
Ivor Royston
Sunesis Pharmaceuticals
Chief Executive Officer
Renée Gal
Jazz Pharmaceuticals
Chief Financial Officer
Chris Tovey
Jazz Pharmaceuticals
Chief Operating Officer
Robert MSCE
Jazz Pharmaceuticals
Executive Vice President, Global Head of Research and Development
Lisa Rojkjaer
Sunesis Pharmaceuticals
Chief Medical Officer
Daniel Chevallard
Sunesis Pharmaceuticals
Chief Financial Officer
Par Hyare
Sunesis Pharmaceuticals
Chief Executive Officer
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019